NL-OMON39481
Completed
Not Applicable
Relevance of Vascular Function Markers: Study on the Effects of Quercetin and Epicatechin on Blood Pressure and Vascular Function in (Pre)Hypertensive Subjects - The FLAVO-studie
TI Food and Nutrition0 sites40 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- High blood pressure
- Sponsor
- TI Food and Nutrition
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Systolic Blood Pressure between 125 and 159 mmHg
- •Age between 30 and 80 years
- •BMI \> 20 and \<\= 40
Exclusion Criteria
- •Hisory of CVD
- •Usage of cholesterol\-lowering medication
- •Usage of non\-steroidal anti\-inflammatory drugs (acetylsalicylic acid, ibuprofen, naproxen) and not able or willing to stop taking them from at least 4 weeks prior to the study
- •Weight loss or weight gain of 5 kg or more during the last 2 months
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A study of clinical usefulness of vascular function.atherosclerosisJPRN-UMIN000039512Hiroshima University Hospital10,000
Recruiting
Not Applicable
The study of biomarkers for intractable vascular anomalies and associated with pharmacological action of sirolimusVascular anomaliesJPRN-UMIN000029173Gifu University50
Completed
Not Applicable
Biomarkers of microvascular function, circulating cells and endothelial integrity in kidney transplant recipients on belatacept or CNICardiovascular disease100110821001265310003216NL-OMON42067ierziekten25
Not yet recruiting
Not Applicable
Cardiovascular health and coenzyme Q10.Coenzyme Q10 levels in people who are currently taking statin therapy to treat high cholesterolDiet and Nutrition - Other diet and nutrition disordersACTRN12607000341426ipid and Diabetes Research Group90
Completed
Not Applicable
Vascular function markers: differences between lean and abdominally overweight / obese men and effects of weight lossNL-OMON39694Medisch Universitair Ziekenhuis Maastricht75